Anton Kraxner
Impact in
- Infectious Diseases top 10%
- Viral Infections and Vectors
- Viral Infections and Outbreaks Research
-
- Mosquito-borne diseases and control
- Malaria Research and Control
Papers in
- Oncology 7
- Peptidase Inhibition and Analysis 6
- Cancer Immunotherapy and Biomarkers 4
-
- Radiopharmaceutical Chemistry and Applications 2
- Monoclonal and Polyclonal Antibodies Research 1
- Co-authors
- Marion Sourisseau (1 shared paper)Lucie Peduto (1 shared paper)Stephen Higgs (1 shared paper)Marc Lecuit (1 shared paper)Marco Colonna (1 shared paper)Nicolas Gangneux (1 shared paper)Clémentine Schilte (1 shared paper)Matthew L. Albert (1 shared paper)
- Journals
- Frontiers in Immunology (3 papers)Journal of Clinical Oncology (2 papers)Annals of Oncology (1 paper)Clinical Cancer Research (1 paper)The Journal of Experimental Medicine (1 paper)
- Partner nations
- SwitzerlandUnited StatesFrance
In The Last Decade
Anton Kraxner
9 papers receiving 319 citations
Peers
Comparison fields: 5 of 36
- Infectious Diseases 185
- Public Health, Environmental and Occupational Health 208
- Virology 22
- Immunology 82
- Oncology 55
Countries citing papers authored by Anton Kraxner
This map shows the geographic impact of Anton Kraxner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anton Kraxner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anton Kraxner more than expected).
Fields of papers citing papers by Anton Kraxner
This network shows the impact of papers produced by Anton Kraxner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anton Kraxner. The network helps show where Anton Kraxner may publish in the future.
Co-authors
The 25 scholars most cited alongside Anton Kraxner, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 264 | |
| 2 | 2024 | 20 | |
| 3 | 2021 | 19 | |
| 4 | 2024 | 8 | |
| 5 | 2021 | 7 | |
| 6 | 2023 | 4 | |
| 7 | 2021 | 3 | |
| 8 | 2024 | 2 | |
| 9 | 2021 | 1 |
About Anton Kraxner
Anton Kraxner is a scholar working on Oncology, Radiology, Nuclear Medicine and Imaging, Immunology, Infectious Diseases and Molecular Biology, having authored 9 papers that have together received 328 indexed citations. Recurring topics across this work include Peptidase Inhibition and Analysis (6 papers), Cancer Immunotherapy and Biomarkers (4 papers), Radiopharmaceutical Chemistry and Applications (2 papers), Cancer Research and Treatments (1 paper), Ubiquitin and proteasome pathways (1 paper), Immunotherapy and Immune Responses (1 paper), Monoclonal and Polyclonal Antibodies Research (1 paper) and Mosquito-borne diseases and control (1 paper). The work is most often cited by research in Infectious Diseases (185 citations), Public Health, Environmental and Occupational Health (208 citations), Virology (22 citations), Immunology (82 citations) and Oncology (55 citations). Anton Kraxner has collaborated with scholars based in Switzerland, United States and France. Frequent co-authors include Marion Sourisseau, Lucie Peduto, Stephen Higgs, Marc Lecuit, Marco Colonna, Nicolas Gangneux, Clémentine Schilte, Matthew L. Albert, Jürg Tschopp and Olivier Schwartz. Their work appears in journals such as Frontiers in Immunology, Journal of Clinical Oncology, Annals of Oncology, Clinical Cancer Research and The Journal of Experimental Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.